A detailed history of Salus Financial Advisors, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Salus Financial Advisors, LLC holds 970 shares of JNJ stock, worth $193,592. This represents 0.12% of its overall portfolio holdings.

Number of Shares
970
Holding current value
$193,592
% of portfolio
0.12%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 20, 2026

BUY
$185.98 - $199.58 $180,400 - $193,592
970 New
970 $201 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Salus Financial Advisors, LLC Portfolio

Follow Salus Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salus Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salus Financial Advisors, LLC with notifications on news.